Related Experiment Video
Updated: Jan 8, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
875
Commercial products and programmes in obesity management
Z Bayat1, S A Bhana2, M Conradie-Smit3
1ivision of Endocrinology, Department of Internal Medicine, Helen Joseph Tertiary Hospital and University of the Witwatersrand, Johannesburg, South Africa.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|December 11, 2025
Summary
Commercial weight loss programs may aid mild weight loss and improve type 2 diabetes markers in adults. However, over-the-counter products lack evidence, and programs do not reliably improve blood pressure or lipid control in obesity.
Area of Science:
- Obesity management and metabolic health.
- Evidence-based recommendations for weight control interventions.
Background:
- Overweight and obesity are significant global health concerns.
- Effective and evidence-based weight management strategies are crucial for public health.
Purpose of the Study:
- To evaluate the efficacy of commercial weight loss programs and products.
- To provide recommendations for the management of overweight and obesity.
Main Methods:
- Systematic review of evidence for commercial weight loss interventions.
- Assessment of impact on weight, glycated haemoglobin, blood pressure, and lipid profiles.
Main Results:
- Commercial programs show potential for mild-to-moderate weight loss and short-term HbA1c reduction in type 2 diabetes.
- Over-the-counter products lack supporting evidence for obesity management.
- Commercial programs do not demonstrate effectiveness in improving blood pressure or lipid control in obesity.
Conclusions:
- Certain commercial programs may offer modest benefits for weight loss and glycemic control in specific populations.
- Lack of evidence precludes recommendation of over-the-counter weight loss products.
- Commercial programs are not recommended for improving cardiovascular risk factors in obesity.
Related Concept Videos
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
01:21Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
01:30Regulation of Food Intake
2.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K
01:26Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293